BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21960365)

  • 21. Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis.
    Scholz C; Nimmrich I; Burger M; Becker E; Dörken B; Ludwig WD; Maier S
    Ann Hematol; 2005 Apr; 84(4):236-44. PubMed ID: 15538567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ADAMTSL5 and CDH11: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia.
    Abdullah M; Choo CW; Alias H; Abdul Rahman EJ; Mohd Ibrahim H; Jamal R; Hussin NH
    Hematology; 2017 Aug; 22(7):386-391. PubMed ID: 28292214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia.
    Melki JR; Vincent PC; Clark SJ
    Cancer Res; 1999 Aug; 59(15):3730-40. PubMed ID: 10446989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypermethylation of the 5' CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia.
    Zheng S; Ma X; Zhang L; Gunn L; Smith MT; Wiemels JL; Leung K; Buffler PA; Wiencke JK
    Cancer Res; 2004 Mar; 64(6):2000-6. PubMed ID: 15026336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Quantitative microarray-based DNA methylation analysis of E-cadherin gene promoter in acute leukemia].
    Chen BA; Zhang F; Wang Y; Zheng WL; Du J; Gao C; Ding JH; Sun YY; Cheng J; Wang J; Zhao G; Chen NN; Lu ZH
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):41-4. PubMed ID: 17575692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid and sensitive detection of CpG-methylation using methyl-binding (MB)-PCR.
    Gebhard C; Schwarzfischer L; Pham TH; Andreesen R; Mackensen A; Rehli M
    Nucleic Acids Res; 2006 Jul; 34(11):e82. PubMed ID: 16822855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation-mediated repression of microRNA-143 enhances MLL-AF4 oncogene expression.
    Dou L; Zheng D; Li J; Li Y; Gao L; Wang L; Yu L
    Oncogene; 2012 Jan; 31(4):507-17. PubMed ID: 21706045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.
    Tang X; Yin X; Xiang T; Li H; Li F; Chen L; Ren G
    Cancer Biomark; 2012-2013; 12(1):11-9. PubMed ID: 23321465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of PCDH10 and its hypermethylation in human gastric cancer.
    Li Z; Chim JC; Yang M; Ye J; Wong BC; Qiao L
    Biochim Biophys Acta; 2012 Feb; 1823(2):298-305. PubMed ID: 22206871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protocadherin-10 acts as a tumor suppressor gene, and is frequently downregulated by promoter methylation in pancreatic cancer cells.
    Qiu C; Bu X; Jiang Z
    Oncol Rep; 2016 Jul; 36(1):383-9. PubMed ID: 27176920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH; Huang LC; Hsu YH
    Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia.
    Agrawal S; Unterberg M; Koschmieder S; zur Stadt U; Brunnberg U; Verbeek W; Büchner T; Berdel WE; Serve H; Müller-Tidow C
    Cancer Res; 2007 Feb; 67(3):1370-7. PubMed ID: 17283175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
    Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
    Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.
    Galm O; Wilop S; Lüders C; Jost E; Gehbauer G; Herman JG; Osieka R
    Ann Hematol; 2005 Dec; 84 Suppl 1():39-46. PubMed ID: 16231140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding.
    Mulero-Navarro S; Carvajal-Gonzalez JM; Herranz M; Ballestar E; Fraga MF; Ropero S; Esteller M; Fernandez-Salguero PM
    Carcinogenesis; 2006 May; 27(5):1099-104. PubMed ID: 16410262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.
    Agirre X; Vilas-Zornoza A; Jiménez-Velasco A; Martin-Subero JI; Cordeu L; Gárate L; San José-Eneriz E; Abizanda G; Rodríguez-Otero P; Fortes P; Rifón J; Bandrés E; Calasanz MJ; Martín V; Heiniger A; Torres A; Siebert R; Román-Gomez J; Prósper F
    Cancer Res; 2009 May; 69(10):4443-53. PubMed ID: 19435910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia.
    Matsushita C; Yang Y; Takeuchi S; Matsushita M; Van Dongen JJ; Szczepanski T; Bartram CR; Seo H; Koeffler HP; Taguchi H
    Oncol Rep; 2004 Jul; 12(1):97-9. PubMed ID: 15201966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias.
    Chim CS; Wong AS; Kwong YL
    Ann Hematol; 2003 Dec; 82(12):738-42. PubMed ID: 14513284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
    Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
    Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
    Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
    Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.